Publishing research using ab56578? Please let us know so that we can cite the reference in this datasheet.
ab56578 has been referenced in 3 publications.
Márk Á et al.Characteristic mTOR activity in Hodgkin-lymphomas offers a potential therapeutic target in high risk disease--a combined tissue microarray, in vitro and in vivo study.BMC Cancer 13:250 (2013).
Serrano I et al.Role of the integrin-linked kinase (ILK)/Rictor complex in TGFß-1-induced epithelial-mesenchymal transition (EMT).Oncogene : (2012).
Lamouille S et al.TGF-ß-induced activation of mTOR complex 2 drives epithelial-mesenchymal transition and cell invasion.J Cell Sci 125:1259-73 (2012).
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"